These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 9577620

  • 1. [Sonographic depiction of woodchuck hepatomas using intravenously injected contrast agents].
    Nada T, Moriyasu F, Kono Y, Matsumura T.
    Nihon Rinsho; 1998 Apr; 56(4):980-4. PubMed ID: 9577620
    [Abstract] [Full Text] [Related]

  • 2. Sonographic detection of tumor blood flow using a new contrast agent in woodchuck hepatomas.
    Nada T, Moriyasu F, Kono Y, Suginoshita Y, Matsumura T, Kobayashi K, Nakamura T, Chiba T.
    J Ultrasound Med; 1997 Jul; 16(7):485-91. PubMed ID: 9315200
    [Abstract] [Full Text] [Related]

  • 3. [Contrast-enhanced power Doppler imaging of the liver--preliminary animal study].
    Matsumura T, Moriyasu F, Kono Y, Chiba T.
    Nihon Rinsho; 1998 Apr; 56(4):985-9. PubMed ID: 9577621
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of galactose-based intravenous contrast medium on color Doppler sonography of deeply located hepatocellular carcinoma.
    Tanaka S, Kitamra T, Yoshioka F, Kitamura S, Yamamoto K, Ooura Y, Imaoka T.
    Ultrasound Med Biol; 1995 Apr; 21(2):157-60. PubMed ID: 7571125
    [Abstract] [Full Text] [Related]

  • 5. [Evaluation of blood flows inside hepatic tumors using color Doppler echography with galactose-based intravenous contrast medium "SH/TA 508" administration].
    Ishii M, Kawauchi A, Sakamoto M, Sasaki K, Kumano Y, Nishida H, Mukai T, Kusano M.
    Nihon Rinsho; 1998 Apr; 56(4):975-9. PubMed ID: 9577619
    [Abstract] [Full Text] [Related]

  • 6. Hepatocellular carcinoma: contrast enhancement with Levovist.
    Choi BI, Kim AY, Lee JY, Kim KW, Lee KH, Kim TK, Han JK.
    J Ultrasound Med; 2002 Jan; 21(1):77-84. PubMed ID: 11794406
    [Abstract] [Full Text] [Related]

  • 7. Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison).
    Jung EM, Kubale R, Jungius KP, Jung W, Lenhart M, Clevert DA.
    Clin Hemorheol Microcirc; 2006 Jan; 34(4):483-97. PubMed ID: 16687788
    [Abstract] [Full Text] [Related]

  • 8. Color doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist.
    Ernst H, Hahn EG, Balzer T, Schlief R, Heyder N.
    J Clin Ultrasound; 1996 Jan; 24(1):31-5. PubMed ID: 8655665
    [Abstract] [Full Text] [Related]

  • 9. Parenchymal enhancement and tumor visualization using a new sonographic contrast agent.
    Forsberg F, Liu JB, Merton DA, Rawool NM, Goldberg BB.
    J Ultrasound Med; 1995 Dec; 14(12):949-57. PubMed ID: 8583531
    [Abstract] [Full Text] [Related]

  • 10. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings.
    Fujimoto M, Moriyasu F, Nishikawa K, Nada T, Okuma M.
    AJR Am J Roentgenol; 1994 Nov; 163(5):1099-104. PubMed ID: 7976882
    [Abstract] [Full Text] [Related]

  • 11. Comparison between color power Doppler ultrasound with echo-enhancer and spiral computed tomography in the evaluation of hepatocellular carcinoma vascularization before and after ablation procedures.
    Cedrone A, Pompili M, Sallustio G, Lorenzelli GP, Gasbarrini G, Rapaccini GL.
    Am J Gastroenterol; 2001 Jun; 96(6):1854-9. PubMed ID: 11419839
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of SH U 508 A (Levovist) in color Doppler ultrasonography of hepatocellular carcinoma vascularization.
    Angeli E, Carpanelli R, Crespi G, Zanello A, Sironi S, Del Maschio A.
    Radiol Med; 1994 May; 87(5 Suppl 1):24-31. PubMed ID: 8209014
    [Abstract] [Full Text] [Related]

  • 13. Feasibility study of an ultrasound contrast agent (levovist) in color Doppler imaging of liver neoplasms.
    Jiang Y, Dai Q, Liu J, Zhang J, Chang X, Cai S, Tan L.
    Chin Med Sci J; 1999 Sep; 14(3):167-9. PubMed ID: 12903818
    [Abstract] [Full Text] [Related]

  • 14. Gray scale second harmonic imaging of the liver: a preliminary animal study.
    Kono Y, Moriyasu F, Nada T, Suginoshita Y, Matsumura T, Kobayashi K, Nakamura T, Chiba T.
    Ultrasound Med Biol; 1997 Sep; 23(5):719-26. PubMed ID: 9253819
    [Abstract] [Full Text] [Related]

  • 15. [Intravenous ultrasound contrast agent, Levovist].
    Kudo M.
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():306-13. PubMed ID: 11761963
    [No Abstract] [Full Text] [Related]

  • 16. [Contrast enhanced color Doppler sonogram of liver tumors: a color-filled pattern in the late phase].
    Tanaka S, Yoshioka F, Kitamra T, Uchimoto R, Niwa K, Miyazawa T.
    Nihon Rinsho; 1998 Apr; 56(4):961-6. PubMed ID: 9577617
    [Abstract] [Full Text] [Related]

  • 17. [Enhanced color flow findings in small hepatocellular carcinoma].
    Maruyama H, Matsutani S, Ebara M, Saisho H.
    Nihon Rinsho; 1998 Apr; 56(4):967-74. PubMed ID: 9577618
    [Abstract] [Full Text] [Related]

  • 18. Ultrasound contrast agent Levovist in colour Doppler sonography of hepatocellular carcinoma in Chinese patients.
    Khong PL, Chau MT, Fan ST, Leong LL.
    Australas Radiol; 1999 May; 43(2):156-9. PubMed ID: 10901894
    [Abstract] [Full Text] [Related]

  • 19. [Vascularization patterns in focal liver lesions: comparison of plain and signal-enhanced amplitude-modulated color duplex ultrasonography].
    Hosten N, Steger W, Bechstein WO, Zendel WJ, Venz S, Lemke AJ, Weber S, Vogl TJ, Felix R.
    Rofo; 1997 Jun; 166(6):507-13. PubMed ID: 9273003
    [Abstract] [Full Text] [Related]

  • 20. On the feasibility of real-time, in vivo harmonic imaging with proteinaceous microspheres.
    Forsberg F, Goldberg BB, Liu JB, Merton DA, Rawool NM.
    J Ultrasound Med; 1996 Dec; 15(12):853-60; quiz 861-2. PubMed ID: 8947861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.